| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Loss before income taxes | -45,149 | -74,125 | -52,691 | -175,644 |
| Income tax (benefit) expense | -92 | -4,288 | 162 | 311 |
| Net loss | -45,057 | -69,837 | -52,853 | -175,955 |
| Net loss attributable to non-controlling interests | -19,501 | -30,246 | -22,908 | -76,917 |
| Net loss attributable to maravai lifesciences holdings, inc | -25,556 | -39,591 | -29,945 | -99,038 |
| Net loss per class a common share attributable to maravai lifesciences holdings, inc., basic (in usd per share) | -0.18 | -0.27 | -0.21 | -0.7 |
| Net loss per class a common share attributable to maravai lifesciences holdings, inc., diluted (in usd per share) | -0.18 | -0.27 | -0.21 | -0.7 |
| Weighted average number of class a common shares outstanding, basic (in shares) | 144,683,000 | 144,236,000 | 143,425,000 | 141,555,000 |
| Weighted average number of class a common shares outstanding, diluted (in shares) | 144,683,000 | 144,236,000 | 143,425,000 | 141,555,000 |
MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)
MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)